Related Experiment Video
Updated: Aug 24, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Pneumococcal endocarditis in children
Laurence B Givner1, Edward O Mason, Tina Q Tan
1Department of Pediatrics, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. lgivner@wfubmc.edu
Insights
Streptococcus pneumoniae endocarditis is rare in children but frequently leads to severe complications. Most affected children had underlying heart conditions, highlighting the need for vigilance in this population.
Area of Science:
- Pediatric Infectious Diseases
- Cardiology
- Vaccinology
Background:
- Endocarditis caused by Streptococcus pneumoniae is uncommon in pediatric populations, representing 3%-7% of childhood endocarditis cases.
- Invasive pneumococcal disease surveillance in children is crucial for understanding disease epidemiology and impact.
Purpose of the Study:
- To describe the clinical characteristics, complications, and outcomes of children diagnosed with Streptococcus pneumoniae endocarditis.
- To assess the serotype distribution of pneumococcal isolates in pediatric endocarditis cases and its relation to vaccination.
Main Methods:
- Prospective surveillance of invasive pneumococcal disease at 8 US children's hospitals from September 1993 to February 2003.
- Clinical data collection on demographics, predisposing conditions, concomitant infections, treatment, and outcomes for children with pneumococcal endocarditis.
Main Results:
- Eleven cases of pediatric pneumococcal endocarditis were identified.
- The majority of affected children were young (3-36 months), male, and had pre-existing structural heart disease, often with prior cardiac surgery.
- Significant complications occurred in 45% of patients, including meningitis, and one patient (9%) died. Most isolates were vaccine serotypes.
Conclusions:
- Pediatric endocarditis due to Streptococcus pneumoniae, though rare, is associated with substantial morbidity and mortality.
- The high prevalence of pre-existing heart disease underscores the importance of early diagnosis and management.
- The presence of vaccine serotypes suggests potential for prevention through pneumococcal vaccination.
Abstract:
Endocarditis due to Streptococcus pneumoniae is unusual in children, accounting for 3%-7% of all cases of childhood endocarditis. The US Pediatric Multicenter Pneumococcal Surveillance Group has prospectively identified patients with invasive disease at 8 children's hospitals. During the period of 1 September 1993 through 28 February 2003, a total of 11 children with pneumococcal endocarditis were seen. Seven (64%) were 3-36 months old; 8 (73%) were boys. Ten (91%) had preexisting structural heart disease; 5 had undergone previous heart surgery. Concomitant sites of infection were noted in 6 patients (55%), including 3 patients with meningitis. One patient (9%) died during hospitalization, and 5 others (45%) experienced serious complications. Only 2 patients remained hospitalized for their entire course of parenteral antibiotic therapy. Eight of 10 pneumococcal isolates tested were vaccine or vaccine-related serotypes included in the currently licensed 7-valent conjugated pneumococcal vaccine. Pneumococcal endocarditis in children is unusual but often has serious complications.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Endocarditis IV: Nursing Management
